DisclosureLens
All entities
norm: abbvieUSLEI FR5LCKFTG8054YNNRU85 · CIK 0001551152Max severity: High
Canonical registry

ABBVIE INC.

ent_019e5f58e459b136cea246d5ddaebd3f

AbbVie Inc. is an American pharmaceutical company that discovers, develops, and commercializes advanced therapies for conditions such as immunology, oncology, and gastroenterology. It is headquartered in North Chicago, Illinois.

AI-summarized from indexed web sources · North Chicago, Illinois · 2026-08-04 · source

Disclosures

7

State AG · Leak Site · 5 jurisdictions

Multi-filing incidents

1

incidents joining 2+ filings here

Max affected reported

1,087

as filed · State AG MT

Leak-site claims

2

unverified actor claims

Identity resolution

Canonical name
ABBVIE INC.
Normalized
abbvie— dedupe via name-norm; Microsoft / MSFT collapse to one row
GLEIF LEI
FR5LCKFTG8054YNNRU85
SEC EDGAR CIK
0001551152
Domain
abbvie.com

Disclosure history (7)newest first

Subsidiary disclosures (1)filed by group companies

◈ These filings were made by or about subsidiaries of ABBVIE INC. — not by ABBVIE INC. itself. Corporate relationships are mapped from GLEIF relationship records and SEC Exhibit 21 filings.

Tracked subsidiariesALLERGAN, INC.